{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:10:17Z","timestamp":1761898217183,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.clinre.2013.02.009","type":"journal-article","created":{"date-parts":[[2013,3,26]],"date-time":"2013-03-26T13:15:39Z","timestamp":1364303739000},"page":"479-484","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Hepatitis C genotype 4 with normal transaminases: Correlation with fibrosis and response to treatment, a cohort Egyptian study of 4277 patients"],"prefix":"10.1016","volume":"37","author":[{"given":"Mahasen","family":"Abdel-Rahman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasmin","family":"Saad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maissa","family":"El-Raziky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naglaa","family":"Zayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wafaa","family":"El-Akel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Said","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"El-Beshlawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gamal","family":"Esmat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2013.02.009_bib0175","first-page":"1","article-title":"NIH consensus statement on management of hepatitis C","volume":"19","author":"National Institute of Health, USA","year":"2002","journal-title":"NIH Consensus State Sci Statements"},{"key":"10.1016\/j.clinre.2013.02.009_bib0010","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/hep.22759","article-title":"Diagnosis management and treatment of hepatitis C: an update AASLD practice guidelines","volume":"49","author":"Ghany","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2013.02.009_bib0015","doi-asserted-by":"crossref","first-page":"961","DOI":"10.7326\/0003-4819-137-12-200212170-00009","article-title":"Prevalence of liver disease in a population of asymptomatic individuals with hepatitis C virus infection","volume":"137","author":"Alberti","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinre.2013.02.009_bib0020","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.jhep.2006.01.004","article-title":"Viral and metabolic factors influencing alanine aminotransferase activity in patients with chronic hepatitis C","volume":"44","author":"Prati","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2013.02.009_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-137-1-200207020-00006","article-title":"Updated definitions of healthy ranges for serum alanine aminotransferase levels","volume":"137","author":"Prati","year":"2002","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.clinre.2013.02.009_bib0030","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1016\/S1665-2681(19)31728-4","article-title":"Clinical approach to the patients with chronic hepatitis C infection and normal aminotransferases","volume":"9","author":"Zapata","year":"2010","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.clinre.2013.02.009_bib0035","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S1590-8658(00)80850-6","article-title":"Hepatitis C virus carriers with persistently normal aminotransferase levels: healthy people or true patients?","volume":"32","author":"Puoti","year":"2000","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.clinre.2013.02.009_bib0040","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0016-5085(00)70145-4","article-title":"Natural history of hepatitis C virus carriers with persistently normal aminotransferase levels","volume":"118","author":"Persico","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2013.02.009_bib0045","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/j.1365-2036.2006.03073.x","article-title":"Review Article: Management of patients with chronic hepatitis C virus infection and normal alanine aminotransferase activity","volume":"24","author":"Zeuzem","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinre.2013.02.009_bib0050","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.cgh.2006.02.002","article-title":"Chronic hepatitis C in patients with persistently normal alanine aminotransferase levels","volume":"4","author":"Shiffman","year":"2006","journal-title":"Clin Gasreoenterol Hepatol"},{"key":"10.1016\/j.clinre.2013.02.009_bib0055","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1053\/jhep.2001.28458","article-title":"Prospective study on anti hepatitis C virus- positive patients with persistently normal serum alanine aminotransferase with or without detectable serum hepatitis C virus RNA","volume":"34","author":"Martinot-Peignoux","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2013.02.009_bib0060","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1365-2893.2005.00667.x","article-title":"Hepatitis C virus carriers with persistently normal ALT levels: Biological peculiarities and update of the natural history of liver disease at 10 years","volume":"13","author":"Persioco","year":"2006","journal-title":"J Viral Hepat"},{"issue":"10 Suppl 2","key":"10.1016\/j.clinre.2013.02.009_bib0065","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1016\/S1542-3565(05)00701-9","article-title":"Natural course of asymptomatic hepatitis C virus- infected patients and hepatocellular carcinoma after Interferon therapy","volume":"3","author":"Okanoue","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2013.02.009_bib0070","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000103901","article-title":"Hepatitis C virus with normal transaminase levels","volume":"25","author":"Puoti","year":"2007","journal-title":"Dig Dis"},{"key":"10.1016\/j.clinre.2013.02.009_bib0075","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.cgh.2008.02.040","article-title":"Hepatitis C infection with normal liver chemistry tests","volume":"6","author":"Fried","year":"2008","journal-title":"Clin Gastroentrol Hepatol"},{"key":"10.1016\/j.clinre.2013.02.009_bib0080","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1053\/jhep.2000.8438","article-title":"Hepatitis C virus (HCV) infection in a community in the Nile Delta: population description and HCV prevalence","volume":"32","author":"Abdel-Aziz","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2013.02.009_bib0085","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0140-6736(99)06527-7","article-title":"The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt","volume":"355","author":"Frank","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.clinre.2013.02.009_bib0090","doi-asserted-by":"crossref","first-page":"236","DOI":"10.4269\/ajtmh.2000.63.236","article-title":"Hepatitis C in a community in Upper Egypt: I Cross-sectional survey","volume":"63","author":"Nafeh","year":"2000","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.clinre.2013.02.009_bib0095","first-page":"367","article-title":"Hepatitis C virus infection at Sharkia Governorate Egypt: seroprevalence and associated risk factors","volume":"34","author":"El-Sadawy","year":"2004","journal-title":"J Egypt Soc Parasitol"},{"key":"10.1016\/j.clinre.2013.02.009_bib0100","article-title":"Hepatitis C in Egypt","author":"Zainab","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinre.2013.02.009_bib0105","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1002\/hep.510260723","article-title":"Therapy of hepatitis C: patients with normal aminotransferase levels","volume":"26","author":"Marcellin","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2013.02.009_bib0110","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0168-8278(02)00101-0","article-title":"Histological and virological features and follow-up of hepatitis C virus carriers with normal aminotransferase levels: the Italian prospective study of the asymptomatic C carriers (ISACC)","volume":"37","author":"Puoti","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2013.02.009_bib0115","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S1590-8658(03)00185-3","article-title":"Clinical management of HCV carriers with normal aminotransferases levels","volume":"35","author":"Puoti","year":"2003","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.clinre.2013.02.009_bib0120","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0016-5085(00)70145-4","article-title":"Natural history of hepatitis C virus carriers with persistently normal aminotransferase levels","volume":"118","author":"Persico","year":"2000","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.clinre.2013.02.009_bib0125","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2893.2009.01150.x","article-title":"Implication of normal liver enzymes in liver disease","volume":"16","author":"Calvaruso","year":"2009","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.clinre.2013.02.009_bib0130","first-page":"418","article-title":"The virological and histological states of anti-hepatitis C virus-positive subjects with normal liver biochemical values","volume":"22","author":"Shindo","year":"1995","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.clinre.2013.02.009_bib0135","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1136\/gut.2004.048009","article-title":"Hepatitis C reactivation in patients with chronic infection with genotypes 1b and 2c: a retrospective cohort study of 206 untreated patients","volume":"54","author":"Rumi","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.clinre.2013.02.009_bib0140","first-page":"413","article-title":"Does the healthy hepatitis C virus carrier state really exist? An analysis using polymerase chain reaction","volume":"22","author":"Prieto","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2013.02.009_bib0145","doi-asserted-by":"crossref","first-page":"S179","DOI":"10.1002\/hep.1840360723","article-title":"Treatment of patients with hepatitis C and normal serum aminotransferase levels","volume":"36","author":"Bacon","year":"2002","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.clinre.2013.02.009_bib0150","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1053\/jhep.2002.35530","article-title":"Predictive value of ALT levels for histologic findings in chronic hepatitis C: a European collaborative study","volume":"36","author":"Pradat","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2013.02.009_bib0155","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/hep.20119","article-title":"Diagnosis, management, and treatment of hepatitis C","volume":"9","author":"Strader","year":"2004","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.clinre.2013.02.009_bib0160","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/hep.23159","article-title":"Impact of pegylated interferon and ribavirin on morbidity and mortality in patients with chronic hepatitis C and normal aminotransferases in France","volume":"50","author":"Deuffic-Burban","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2013.02.009_bib0165","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1053\/j.gastro.2004.09.050","article-title":"Peg interferon alpha 2-a(40 kilodalton) and ribavirin in patients with chronic hepatitis C and normal aminotransferase levels","volume":"127","author":"Zeuzem","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2013.02.009_bib0170","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1111\/j.1478-3231.2009.02042.x","article-title":"Treatment of hepatitis C virus carriers with persistently normal alanine aminotransferase levels with peg interferon alpha 2-a and ribavirin: a multicentric study","volume":"29","author":"Puoti","year":"2009","journal-title":"Liver Int"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740113000454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740113000454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:18:45Z","timestamp":1761895125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740113000454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S2210740113000454"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2013.02.009","relation":{},"ISSN":["2210-7401"],"issn-type":[{"type":"print","value":"2210-7401"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis C genotype 4 with normal transaminases: Correlation with fibrosis and response to treatment, a cohort Egyptian study of 4277 patients","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2013.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}